Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07608562 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Azithromycin for Cerclage Prophylaxis

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Aug 2026 to Sep 2026v4
  2. Interventions: Azithromycin Placebo (Drug), Azithromycin Prophylaxis (Drug), Cefazolin (Drug) to Azithromycin Placebo (Drug), Azithromycin Prophylaxis (Drug), Cefazolin (Drug), Progesterone (Drug)v3
  3. Start date: Jun 2026 to Aug 2026v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary goal is to assess the effectiveness in pregnancy prolongation utilizing azithromycin at the time of transvaginal cervical cerclage placement.
Trial Details
NCT Number NCT07608562
Lead Sponsor Wake Forest University Health Sciences
Conditions
(from sponsor)		 Cervical Insufficiency
Related terms Uterine Cervical Incompetence
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov